Free Trial
NASDAQ:TSRX

(TSRX) (TSRX) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free TSRX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
TSRX stock logo

About (TSRX) Stock (NASDAQ:TSRX)

Trius Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibiotics for life threatening infections. The Company is developing torezolid phosphate, an intraveneous (IV) and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections (ABSSSI), and subsequently for other indications. In addition, the Company is developing antibiotics for gram-negative infections using its discovery platform under two contracts: one funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) and the other funded by the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense. In September 2013, Cubist Pharmaceuticals Inc announced that it has completed the acquisition of Trius Therapeutics Inc.

TSRX Stock News Headlines

January 18, 2023 | msn.com
As she turns 103, ‘nothing tastes better at a party than crab cakes and beer’
See More Headlines
Receive TSRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (TSRX) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:TSRX
CUSIP
89685K10
CIK
1356857
Web
www.triusrx.com
Phone
+1-781-8608660
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

TSRX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (TSRX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (TSRX) investors own include InvenSense (INVN), (MCPIQ) (MCPIQ), OPKO Health (OPK), Pharmacyclics (PCYC), AbbVie (ABBV), ACADIA Pharmaceuticals (ACAD), AcelRx Pharmaceuticals (ACRX), American International Group (AIG), Alkermes (ALKS) and Alnylam Pharmaceuticals (ALNY).

This page (NASDAQ:TSRX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
American Alternative
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders